Celularity Inc - 8-K Filing
Celularity Inc. appointed Rick Gonzalez as Chief Commercial Officer, effective May 29, 2026, to lead global commercial strategy for cenplacel-L and Lifebank. The company also disclosed a shareholder letter from CEO Robert J. Hariri outlining strategic focus on longevity, regenerative medicine, and the preservation of human performance. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $CELU